science

Technology transfer, or the practice of transferring scientific findings from one organization, most notably universities, to another for further development, plays a pivotal role in the R&D ecosystem. It is the bridge that ensures knowledge cultivated through academic research reaches patients and other beneficiaries, and it is a critically important means of financing further science and technology at academic institutions in the U.S. and around the world. The Association of University Technology Managers (AUTM), a nonprofit organization with an international membership of more than 3,000 technology managers and business executives, has developed a project that not only highlights the...
Each blockbuster drug, every novel vaccine or innovative therapy now heralded as a lifesaving miracle had the humblest of beginnings – as a project in a scientist’s lab. Through years of study and millions of dollars invested, these discoveries became the groundbreaking treatments that changed people’s lives. A scientist’s idea and a medicine’s path to patients who need it is one of the best stories out there, and we at Spectrum get to tell it every day. Spectrum is a proud member of Research!America. We are a public relations firm serving clients exclusively in health, medicine and life science, and we share Research!America’s passion for medical research and the promise of scientific...
Excerpt of an op-ed by Research!America President and CEO Mary Woolley published in the Huffington Post . As the new Congress sets priorities, there are strong indications that the political climate is ripe for a surge in science. Bipartisan support for the 21st Century Cures Initiative, a comprehensive study of roadblocks to medical innovation and development of new disease therapies and treatments, is slated to move forward with draft legislation early next year. The measure is expected to address six areas of reform: integrating patients’ perspectives into the regulatory process, modernizing clinical trials, fostering the future of science, investing in advancing research, incentivizing...
We applaud the confirmation of Dr. Vivek Murthy as U.S. surgeon general, a visionary thinker who is well-equipped to assume the role of America’s doctor. Throughout his career he has demonstrated a strong commitment to improving public health and unwillingness to accept the status quo: invaluable traits for such challenges as combating Ebola, the obesity epidemic, tobacco-related disease and other complex health issues that confront our nation. His determination to hit the ground running to address health disparities and reduce the stigma of mental health, with a clear understanding of the role of science and innovation in improving health outcomes, is also critically important to advancing...
Dear Research Advocate: Ebola remains in the news. In the midst of the demoralizing finger pointing that seems to have taken the place of unity of mission that ought to characterize our nation, we are occasionally reminded that science is a problem solver. That’€™s a useful message to convey if we hope to keep the current politicization from worsening. But more of us have to speak out. Don’€™t stand on the sidelines when you could make a difference at this important time when people are paying much more attention to research than usual. With the election only a little over a week away, take the time to ask candidates a question or two. Email or tweet in questions to debates and contact...
Dear Research Advocate: The 2014 Nobel Laureates will be announced next week. I hope you will consider amplifying the news via social media, op-eds and letters to the editor. The Nobel prize is so iconic that it provides an entrée to the broader public, one that can be used to connect the dots between the process of scientific discovery, the power of ingenuity, and the role of science in human progress. And if a winner has been funded by a U.S. science agency or company, all the better from an advocacy perspective! In the years ahead, will the United States be home to more Nobel Laureates in the sciences, or will those honors go to scientists in countries that place a greater emphasis on...
Dear Research Advocate: The loss of American Icon Robin Williams has riveted national attention on suicide, one of the 10 most common causes of death in the United States. Today, we are releasing our updated fact sheet on suicide that you can use when meeting with lawmakers and educating others about the impact research can have. Efforts to prevent suicide rightly draw on research findings. But progress has been painfully slow, stymied by serious gaps – partly due to severely limited funding – in the basic research base that precedes private sector development, and stymied by the equivalent of handcuffs placed on social science research. The notion promulgated by some in the Congress that...
On July 23, the Society for Neuroscience held its first interactive webinar titled “Communicating Your Science to the Non-Expert.” During the webinar, speakers discussed how to effectively describe the health and economic impact of your research to a nonscientific audience including policymakers and the media. The presentation covers the basics of crafting an elevator speech and a question and answer session with scientists. Watch the entire recording online or one chapter at a time: Part 1: Introduction , Scott Thompson, PhD, professor and chair for the Department of Physiology, University of Maryland School of Medicine Part 2: Why Communicate? , Scott Thompson, PhD Part 3: Crafting Your...
By Ellen L. Woods, President of the American Foundation for Pharmaceutical Education The American Foundation for Pharmaceutical Education (AFPE) is a national nonprofit organization located in Arlington, VA. AFPE was founded in 1942 and is the oldest pharmacy foundation in the nation. Now for more than 70 years, AFPE has provided fellowships, scholarships and grants to help educate thousands of the very best and brightest students in the pharmaceutical sciences in preparation for distinguished careers. AFPE fellows engage in important, cutting-edge drug research that affects health outcomes in areas across the spectrum, from diabetes, heart disease, cancer, obesity, Alzheimer’€™s and other...
Dear Research Advocate: In recognition of his many accomplishments as a champion for research, Research!America Chair and former Congressman John Edward Porter was honored by the National Academy of Sciences with the Public Welfare Medal, the Academy’€™s most prestigious award. This well-deserved acknowledgment of Porter’€™s tireless efforts to advance innovation and engage scientists in advocacy should motivate advocates to follow his lead and speak up about threats to our nation’€™s research ecosystem. Read our statement on the award ceremony here . In his remarks , Mr. Porter noted that ’€œpolitical judgment should never be allowed to be substituted for scientific judgment.’€ This point...

Pages

Sidebar Quote

Funding research gives all of us a better chance of living a healthier life.
Pam Hirata, heart disease survivor